ClinicalTrials.gg

Affinivax, Inc. clinical trials

Acquired by GlaxoSmithKline, Aug 15, 2022 · source ↗

The registry lists 2 studies whose lead sponsor is Affinivax, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 6, 2022.

Before and after it joined GlaxoSmithKline

First submitted before Affinivax, Inc. became part of GlaxoSmithKline
2
First submitted after Affinivax, Inc. became part of GlaxoSmithKline
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Affinivax, Inc.’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 2 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed2100%

Phase

  • Phase 12

Where

  • United States1
  • Japan1

Over the years

  1. 220
  2. 21
  3. 22
  4. 23
  5. 24
  6. 25
  7. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Affinivax, Inc.2 studies

Something wrong with this grouping? Tell us on the GlaxoSmithKline page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All GlaxoSmithKline studies →